Arthritis can affect more than your joints; it can cause other health problems throughout the body. Certain types of arthritis may even play a role in cancer, as researchers recently found.

There are two major types of lung cancer. The most common type is called non-small cell lung cancer. Small cell lung cancer makes up only about 15 percent of the 226,000 cases of lung cancer diagnosed in the US every year. New treatments for this more aggressive lung cancer may be on the horizon.

Kidney cancer doesn’t usually have any warning signs until it has become pretty serious. In fact, about a third of patients are diagnosed with an advanced stage of the disease. A medication has been approved in Europe to treat kidney cancer that has spread.

Chemotherapy can hurt the body’s ability to fight off infection. The cancer-killing medicines lower the number of infection-fighting white blood cells. The condition is called neutropenia and another option is now available to treat it.

A rare type of brain tumor called SEGA ( subependymal giant cell astrocytoma ) can appear in children. The drug designed to take on this cancer is too strong for young patients. Now a new children’s dosage of a medication has been approved.

Your pancreas is the organ that makes insulin - a hormone that plays a key role in diabetes control. Without a pancreas, controlling diabetes could be difficult; at least that's what doctors thought.

Along the road to improving diabetes care, both doctors and scientists have disagreed about which treatments are best. Now, there is disagreement about the safety of one of the most common diabetes drugs.

There's mounting evidence that a person’s weight and BMI (body mass index) at the time of their cancer diagnosis can make a difference in the course of the disease. Weight loss, if needed, is usually a positive move for people with cancer – but not for all.

When monitored and managed properly, the outlook is quite good for people living with chronic myeloid leukemia ( CML ). There are three targeted therapies that are effective in controlling this disease. One of the keys to success is close monitoring.

Gastrointestinal stromal tumors (GIST) are known as soft tissue sarcomas. They can appear anywhere along the digestive tract. They most commonly start in the stomach. A new drug to treat GIST is headed for review by the U.S. Food and Drug Administration (FDA).